Skip to main content
. 2015 Jan 26;20(3):488–495. doi: 10.1111/resp.12474

Table 6.

Bronchostenosis in patients with central EBTB after standard anti-tuberculosis therapy

Persistent bronchostenosis after treatment P-value
Grade 1 (%) Grade 2 or 3 (%)
Initial luminal narrowing in central EBTB Grade 1 (n = 106) 86 (81.1) 20 (18.9) 0.450
Grade 2 (n = 19) 13 (68.4) 6 (31.6)
Grade 3 (n = 20) 16 (80.0) 4 (20.0)
Total 145 115 (79.3) 30 (20.7)

EBTB, endobronchial tuberculosis.